$2.51 0.00 (0.00%) Rigel Pharmaceuticals Inc - NASDAQ

Jan. 13, 2017 | 04:00 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 2.51
Trade Time: Jan 13 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 2.51
Open: 2.44
Bid: 2.01
Ask: 3.00

Competitors

Ticker Name Volume % Change
PDLI PDL BioPharma Inc. 3.73M -0.87%
EXAS EXACT Sciences Corporation 3.37M -0.16%
AKAO Achaogen 2.27M +13.60%
SGMO Sangamo BioSciences Inc. 2.00M +11.39%
CYTR CytRx Corporation 1.61M +4.23%

RIGL Stock Analysis

Partner Headlines

  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 06:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST